BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Günaltay S, Nyhlin N, Kumawat AK, Tysk C, Bohr J, Hultgren O, Hörnquist EH. Differential expression of interleukin-1/Toll-like receptor signaling regulators in microscopic and ulcerative colitis. World J Gastroenterol 2014; 20(34): 12249-12259 [PMID: 25232259 DOI: 10.3748/wjg.v20.i34.12249] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Mihaly E, Patai Á, Tulassay Z. Controversials of Microscopic Colitis. Front Med (Lausanne) 2021;8:717438. [PMID: 34712675 DOI: 10.3389/fmed.2021.717438] [Reference Citation Analysis]
2 Bai J, Li Y, Li M, Tan S, Wu D. IL-37 As a Potential Biotherapeutics of Inflammatory Diseases. Curr Drug Targets 2020;21:855-63. [PMID: 32348214 DOI: 10.2174/1389450121666200429114926] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
3 Tong J, Wang X, Liu Y, Ren X, Wang A, Chen Z, Yao J, Mao K, Liu T, Meng FL, Pan W, Zou Q, Liu J, Zhou Y, Xia Q, Flavell RA, Zhu S, Li HB. Pooled CRISPR screening identifies m6A as a positive regulator of macrophage activation. Sci Adv 2021;7:eabd4742. [PMID: 33910903 DOI: 10.1126/sciadv.abd4742] [Cited by in Crossref: 2] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
4 Liu S, He C, Liao Y, Liu H, Mao W, Shen Z. Enhancing and Complementary Mechanisms of Synergistic Action of Acori Tatarinowii Rhizoma and Codonopsis Radix for Alzheimer's Disease Based on Systems Pharmacology. Evid Based Complement Alternat Med 2020;2020:6317230. [PMID: 32802132 DOI: 10.1155/2020/6317230] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Miehlke S, Verhaegh B, Tontini GE, Madisch A, Langner C, Münch A. Microscopic colitis: pathophysiology and clinical management. Lancet Gastroenterol Hepatol 2019;4:305-14. [PMID: 30860066 DOI: 10.1016/S2468-1253(19)30048-2] [Cited by in Crossref: 53] [Cited by in F6Publishing: 23] [Article Influence: 26.5] [Reference Citation Analysis]
6 Yan H, Zhang X, Xu Y. Aberrant expression of miR-21 in patients with inflammatory bowel disease: A protocol for systematic review and meta analysis. Medicine (Baltimore) 2020;99:e19693. [PMID: 32332611 DOI: 10.1097/MD.0000000000019693] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
7 Jia Y, Anwaar S, Li L, Yin Z, Ye Z, Huang Z. A new target for the treatment of inflammatory bowel disease: Interleukin-37. Int Immunopharmacol 2020;83:106391. [PMID: 32208166 DOI: 10.1016/j.intimp.2020.106391] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
8 Zhu F, Li H, Liu Y, Tan C, Liu X, Fan H, Wu H, Dong Y, Yu T, Chu S, He H, Zhu X. miR-155 antagomir protect against DSS-induced colitis in mice through regulating Th17/Treg cell balance by Jarid2/Wnt/β-catenin. Biomed Pharmacother 2020;126:109909. [PMID: 32135463 DOI: 10.1016/j.biopha.2020.109909] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
9 Su L, Xu W, Huang A. IRAK family in inflammatory autoimmune diseases. Autoimmunity Reviews 2020;19:102461. [DOI: 10.1016/j.autrev.2020.102461] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
10 Ren TH, Lv MM, An XM, Leung WK, Seto WK. Activation of adenosine A3 receptor inhibits inflammatory cytokine production in colonic mucosa of patients with ulcerative colitis by down-regulating the nuclear factor-kappa B signaling. J Dig Dis 2020;21:38-45. [PMID: 31714673 DOI: 10.1111/1751-2980.12831] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
11 Larsson JK, Dabos KJ, Höglund P, Bohr J, Münch A, Giannakou A, Nemeth A, Wurm-Johansson G, Toth E, Plevris JN, Fineron P, Koulaouzidis A, Sjöberg K. Cancer Risk in Collagenous Colitis. J Clin Med 2019;8:E1942. [PMID: 31718057 DOI: 10.3390/jcm8111942] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
12 McEntee CP, Finlay CM, Lavelle EC. Divergent Roles for the IL-1 Family in Gastrointestinal Homeostasis and Inflammation. Front Immunol 2019;10:1266. [PMID: 31231388 DOI: 10.3389/fimmu.2019.01266] [Cited by in Crossref: 11] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
13 Mosso E, Boano V, Grassini M, Battaglia E, Pellicano R. Microscopic colitis: a narrative review with clinical approach. Minerva Gastroenterol Dietol 2019;65:53-62. [PMID: 30486642 DOI: 10.23736/S1121-421X.18.02539-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
14 Feng W, Ao H, Yue S, Peng C. Systems pharmacology reveals the unique mechanism features of Shenzhu Capsule for treatment of ulcerative colitis in comparison with synthetic drugs. Sci Rep 2018;8:16160. [PMID: 30385774 DOI: 10.1038/s41598-018-34509-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
15 Wang P, Wang H, Li C, Zhang X, Xiu X, Teng P, Wang Z. Dysregulation of microRNA‐657 influences inflammatory response via targeting interleukin‐37 in gestational diabetes mellitus. J Cell Physiol 2019;234:7141-8. [DOI: 10.1002/jcp.27468] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
16 Wang L, Quan Y, Yue Y, Heng X, Che F. Interleukin-37: A crucial cytokine with multiple roles in disease and potentially clinical therapy. Oncol Lett 2018;15:4711-9. [PMID: 29552110 DOI: 10.3892/ol.2018.7982] [Cited by in Crossref: 8] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
17 Begka C, Velin D, Maillard MH. Preventing Overheating: Tight Control of Gut Innate Immunity in Health and Disease. Inflamm Bowel Dis 2016;22:1723-36. [PMID: 27271495 DOI: 10.1097/MIB.0000000000000838] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
18 Dinarello CA, Nold-Petry C, Nold M, Fujita M, Li S, Kim S, Bufler P. Suppression of innate inflammation and immunity by interleukin-37. Eur J Immunol 2016;46:1067-81. [PMID: 27060871 DOI: 10.1002/eji.201545828] [Cited by in Crossref: 120] [Cited by in F6Publishing: 139] [Article Influence: 24.0] [Reference Citation Analysis]
19 Günaltay S, Repsilber D, Helenius G, Nyhlin N, Bohr J, Hultgren O, Hultgren Hörnquist E. Oligoclonal T-cell Receptor Repertoire in Colonic Biopsies of Patients with Microscopic Colitis and Ulcerative Colitis: . Inflammatory Bowel Diseases 2017;23:932-45. [DOI: 10.1097/mib.0000000000001127] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
20 Pastorelli L, Pizarro TT. Interleukin-37: A Peacekeeper at the Intestinal Borders. Dig Dis Sci 2017;62:1103-6. [PMID: 28289924 DOI: 10.1007/s10620-017-4523-0] [Reference Citation Analysis]
21 Günaltay S, Ghiboub M, Hultgren O, Hörnquist EH. Reduced IL-37 Production Increases Spontaneous Chemokine Expressions in Colon Epithelial Cells. Dig Dis Sci 2017;62:1204-15. [PMID: 28044228 DOI: 10.1007/s10620-016-4422-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
22 Rothschild DE, Zhang Y, Diao N, Lee CK, Chen K, Caswell CC, Slade DJ, Helm RF, LeRoith T, Li L, Allen IC. Enhanced Mucosal Defense and Reduced Tumor Burden in Mice with the Compromised Negative Regulator IRAK-M. EBioMedicine 2017;15:36-47. [PMID: 27939424 DOI: 10.1016/j.ebiom.2016.11.039] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
23 Pisani LF, Tontini GE, Vecchi M, Pastorelli L. Microscopic Colitis: What Do We Know About Pathogenesis? Inflamm Bowel Dis 2016;22:450-8. [PMID: 26529562 DOI: 10.1097/MIB.0000000000000628] [Cited by in Crossref: 40] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
24 Szűcs D, Béres NJ, Rokonay R, Boros K, Borka K, Kiss Z, Arató A, Szabó AJ, Vannay &, Sziksz E, Bereczki C, Veres G. Increased duodenal expression of miR-146a and -155 in pediatric Crohn’s disease. World J Gastroenterol 2016; 22(26): 6027-6035 [PMID: 27468194 DOI: 10.3748/wjg.v22.i26.6027] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
25 Carrasco A, Esteve M, Salas A, Pedrosa E, Rosinach M, Aceituno M, Zabana Y, Fernández-Bañares F. Immunological Differences between Lymphocytic and Collagenous Colitis. J Crohns Colitis 2016;10:1055-66. [PMID: 26928959 DOI: 10.1093/ecco-jcc/jjw058] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
26 Li GH, Guo CQ, Liu QQ. Bowel preparation with polyethylene glycol electrolyte powder lowers serum levels of IL-6 and CRP in patients with mild to moderate active ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2015; 23(35): 5711-5714 [DOI: 10.11569/wcjd.v23.i35.5711] [Reference Citation Analysis]
27 Xu W, Zhao Y, Liu Y. Insights into IL-37, the role in autoimmune diseases. Autoimmunity Reviews 2015;14:1170-5. [DOI: 10.1016/j.autrev.2015.08.006] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 7.1] [Reference Citation Analysis]
28 Bohr J, Wickbom A, Hegedus A, Nyhlin N, Hultgren Hörnquist E, Tysk C. Diagnosis and management of microscopic colitis: current perspectives. Clin Exp Gastroenterol. 2014;7:273-284. [PMID: 25170275 DOI: 10.2147/ceg.s63905] [Cited by in Crossref: 2] [Cited by in F6Publishing: 15] [Article Influence: 0.3] [Reference Citation Analysis]